Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients

Fig. 3

Comparison of the cumulative ESRD-free survival rates. A AAV patients with GA ≥ 14.25% exhibited significantly lower cumulative ESRD-free survival rates than those without; B the cumulative ESRD-free survival rates did not differ between AAV patients with GA/HbA1c ≥ 2.82 and those without. ESRD: end-stage renal disease; GA: glycated albumin; HbA1c: glycated haemoglobin

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us